🇬🇧July 15, 2026·6d agoResearch

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial

Publisher

PubMed Lancet RSS

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: PubMed Lancet RSS
Region: UK
Scope: Research
Published: July 15, 2026
Language: EN

Topics

journal

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on pubmed.ncbi.nlm.nih.gov

Leave the platform to read the original full article on the publisher site.

Source: PubMed Lancet RSS

Scope: Research

Open original article

Related coverage

More related coverage

Northwestern Medicine/1h ago

Northwestern Medicine study finds women experience more severe neurological symptoms of long COVID than men

Universitätsspital Zürich (USZ)/1h ago

Freizeit-Krankheit: Warum werden viele Menschen im Urlaub oder am Wochenende krank?

Universitätsspital Zürich (USZ)/4h ago

Von der Krebsdiagnose zum Cancer Survivor

Hospital Universitario La Paz (Madrid)/4h ago

El Hospital Universitario de Móstoles ofrece recomendaciones para que las personas con ostomía disfruten de un verano seguro y activo

El Hospital Universitario de Móstoles ofrece recomendaciones para que las personas con ostomía disfr...